Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Harvard Business School
AstraZeneca
Chinese Patent Office
Queensland Health
Boehringer Ingelheim
US Army
QuintilesIMS
UBS

Generated: May 23, 2018

DrugPatentWatch Database Preview

LOTEMAX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Drug patent expirations by year for LOTEMAX
Pharmacology for LOTEMAX
Medical Subject Heading (MeSH) Categories for LOTEMAX
Synonyms for LOTEMAX
034L466
82034-46-6
AB00698349_08
AB00698349-05
AB00698349-07
AB2000207
AC1L9FKJ
AKOS005145741
Alrex
Alrex, Lotemax, Loteprednol etabonate
Alrex;Lotemax
Androsta-1,4-diene-17-carboxylic acid, 17-((ethoxycarbonyl)oxy)-11-hydroxy-3-oxo-, chloromethyl ester, (11beta,17alpha)-
C24H31ClO7
CAS-82034-46-6
CCG-101041
CDDD 5604
CDDD-5604
CHEBI:31784
CHEMBL1200865
chloromethyl (1S,2R,10S,11S,14R,15S,17S)-14-[(ethoxycarbonyl)oxy]-17-hydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-14-carboxylate
chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-((ethoxycarbonyl)oxy)-11-hydroxy-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carb
chloromethyl (8S,9S,10R,11S,13S,14S,17R)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
Chloromethyl 11beta,17-dihydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate, 17-(ethyl carbonate)
chloromethyl 17alpha-[(ethoxycarbonyl)oxy]-11beta-hydroxy-3-oxoandrosta-1,4-diene-17beta-carboxylate
CS-0900
D01689
D0X6GN
DMKSVUSAATWOCU-HROMYWEYSA-N
DSSTox_CID_26468
DSSTox_GSID_46468
DSSTox_RID_81641
DTXSID2046468
GS-3599
GTPL7085
HGP 1
HGP-1
HMS2051F16
HMS2232J09
HY-17358
IDR-90102
IDR-90103
Inveltys
K462
Locort
Loteflam
Lotemax (TN)
Loteprednol etabonate
Loteprednol etabonate (JAN/USAN)
Loteprednol etabonate [USAN:JAN]
Loteprednol etabonate Opphthalmic suspension
Loteprednol Etabonate, >=98% (HPLC)
Loterox
MLS001424221
MolPort-003-848-424
NC00291
NCGC00164594-01
NCGC00164594-02
P 5604
P-5604
s1669
SCHEMBL23907
SMR000469178
ST24030829
Tox21_112219
Tox21_112219_1
UNII-YEH1EZ96K6
YEH1EZ96K6
ZINC3920673

US Patents and Regulatory Information for LOTEMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb Inc LOTEMAX loteprednol etabonate GEL;OPHTHALMIC 202872-001 Sep 28, 2012 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Pharmos LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020841-001 Mar 9, 1998 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bausch And Lomb LOTEMAX loteprednol etabonate OINTMENT;OPHTHALMIC 200738-001 Apr 15, 2011 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bausch And Lomb LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020583-001 Mar 9, 1998 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for LOTEMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch And Lomb LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020583-001 Mar 9, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Bausch And Lomb Inc LOTEMAX loteprednol etabonate GEL;OPHTHALMIC 202872-001 Sep 28, 2012 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmos LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020841-001 Mar 9, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Pharmos LOTEMAX loteprednol etabonate SUSPENSION/DROPS;OPHTHALMIC 020841-001 Mar 9, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Boehringer Ingelheim
Federal Trade Commission
Daiichi Sankyo
Queensland Health
UBS
Harvard Business School
Fish and Richardson
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.